|
End-of-day quote
Johannesburg S.E.
2026-11-10
|
5-day change | 1st Jan Change | ||
| 173.75 ZAR | +2.90% |
|
+6.10% | +48.77% |
| 04:18am | Aspen Pharmacare wins approval for generic semaglutide in Brazil, South Africa | RE |
| 02:14am | Aspen Pharmacare gets nod for generic semaglutide in Brazil, South Africa | RE |
| Market Cap | 76.1B 4.58B 4.13B 3.82B 3.45B 6.53B 430B 6.69B 45.74B 18.23B 230B 17.2B 16.84B 733B | P/E 2027 * |
14.8x | P/E 2028 * | 14.2x |
|---|---|---|---|---|---|
| Enterprise Value | 73.23B 4.41B 3.98B 3.67B 3.32B 6.28B 414B 6.44B 44.02B 17.54B 222B 16.55B 16.2B 705B | EV / Sales 2027 * |
1.98x | EV / Sales 2028 * | 1.81x |
| Free-Float |
58.39% | Yield 2027 * |
1.74% | Yield 2028 * | 1.72% |
| Markets | Quality | ||
|---|---|---|---|
Johannesburg S.E.
| APN | End-of-day quote | |
OTC Markets
| APNHF | Delayed | |
|
Deutsche Boerse AG
| LDZA | Delayed | |
|
Tradegate
| LDZA | Real-time | |
|
Börse Stuttgart
| LDZA | Delayed | |
|
Boerse Muenchen
| LDZA | Real-time |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | +2.90% | ||
| 1 week | +6.10% | ||
| Current month | +9.97% | ||
| 1 month | +9.79% | ||
| 3 months | +14.15% | ||
| 6 months | +18.48% | ||
| Current year | +48.77% |
| 1 week | 161.25 |  | 175.55 |
| 1 month | 152.19 | | 175.55 |
| Current year | 104.38 | | 175.55 |
| 1 year | 90.7 | | 175.55 |
| 3 years | 90.7 | | 252.96 |
| 5 years | 90.7 | | 252.96 |
| 10 years | 64.07 | | 327.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 1996-12-31 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 2008-12-31 |
| Chief Operating Officer | 63 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Saad
BRD | Director/Board Member | 62 | 1998-12-31 |
| Director/Board Member | 65 | 1998-12-31 | |
Kuseni Dlamini
CHM | Chairman | 58 | 2015-12-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/27/23 | Free | Chief Operating Officer | 12,236 | 0.0027% | ||
| 9/27/23 | Free | Executive/Senior Manager | 11,728 | 0.0026% | ||
| 9/27/23 | Free | Founder | 10,558 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.90% | +6.10% | +79.40% | +1.44% | 4.63B | |
| +0.35% | +1.98% | +48.69% | +140.47% | 1,276B | |
| -0.13% | +5.35% | +48.83% | +90.43% | 676B | |
| +0.37% | +3.14% | +34.87% | +112.84% | 519B | |
| +0.02% | +2.79% | +44.10% | +69.76% | 388B | |
| -0.59% | +1.73% | +69.66% | +45.16% | 365B | |
| -1.29% | +0.94% | +29.88% | +58.29% | 307B | |
| +0.09% | +0.99% | +5.87% | +37.72% | 287B | |
| +0.62% | +1.49% | +44.63% | +75.12% | 252B | |
| -0.67% | +1.35% | +43.66% | +123.56% | 212B | |
| Average | +0.56% | +2.71% | +44.96% | +75.48% | 429B | |
| Weighted average by Cap. | +0.48% | +2.51% | +43.74% | +97.12% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 36.93B 2.22B 2B 1.85B 1.67B 3.17B 209B 3.25B 22.2B 8.85B 112B 8.35B 8.17B 356B | 38.87B 2.34B 2.11B 1.95B 1.76B 3.33B 220B 3.42B 23.36B 9.31B 118B 8.79B 8.6B 374B |
| Net income | 5.13B 309M 279M 257M 233M 440M 28.99B 451M 3.08B 1.23B 15.53B 1.16B 1.14B 49.41B | 5.08B 306M 276M 255M 230M 436M 28.68B 446M 3.05B 1.22B 15.36B 1.15B 1.12B 48.88B |
| Net Debt | -2.87B -173M -156M -144M -130M -246M -16.22B -252M -1.73B -688M -8.69B -649M -635M -27.64B | -5.71B -344M -310M -287M -259M -490M -32.28B -502M -3.43B -1.37B -17.29B -1.29B -1.26B -55.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-11 | ZAR 172.33 | -0.82% | 791,446 |
| 26-11-10 | ZAR 173.75 | +2.90% | 1,338,897 |
| 26-11-09 | ZAR 168.86 | +1.48% | 579,790 |
| 26-11-06 | ZAR 166.39 | -0.47% | 530,440 |
| 26-11-05 | ZAR 167.17 | +2.08% | 1,125,626 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- APN Stock
Select your edition
All financial news and data tailored to specific country editions
